Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02327312

Enrollment

Registered

2014-12-30

Start date

2014-12-16

Completion date

2020-08-11

Last updated

2022-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Open-Angle Glaucoma

Brief summary

To evaluate the safety and effectiveness of Trabecular Micro-Bypass stents (two stents per study eye) vs. laser trabeculoplasty, in subjects with open angle glaucoma

Interventions

DEVICEStents

Two Trabecular meshwork Micro-Bypass stents into the study eye

PROCEDURELaser

Laser Trabeculoplasty

DEVICELaser Trabeculoplasty

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

35 Years to No maximum

Healthy volunteers

Inclusion criteria

* Open angle Glaucoma

Exclusion criteria

* Active corneal inflammation or edema * Choroidal detachment, effusion, choroiditis

Design outcomes

Primary

Measure	Time frame
IOP reduction	up to 24 months

Secondary

Measure	Time frame
% IOP reduction	up to 24 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026